*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| D287 - Benign neoplasm of other specified female genital organs - as a primary diagnosis code | D287 - Benign neoplasm of other specified female genital organs - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 4.94 | |
| Readmission Rate (%) | 11.15 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 743: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 742: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 24,415 | |
| Total Hospitalizations with ICD D287 - Benign neoplasm of other specified female genital organs | 64 | |
| DRG Share of Total Hospitalizations | 0.07 | |
| % of Total ICD D287 - Benign neoplasm of other specified female genital organs in DRG | 51.61 | |
| Avg LOS at DRG | 1.87 | |
| Avg LOS with ICD D287 - Benign neoplasm of other specified female genital organs | 2.41 | |
| Readmission Rate at DRG | 4.31 | |
| Readmission Rate with ICD D287 - Benign neoplasm of other specified female genital organs | NA | |
| Unplanned Readmission Rate at DRG | 3.22 | |
| Unplanned Readmission Rate with ICD D287 - Benign neoplasm of other specified female genital organs | NA | |
| Total Medicare payments at DRG | $140,286,858 | |
| Total Medicare payments with ICD D287 - Benign neoplasm of other specified female genital organs | $421,157 | |
| Total Medicare payment per Day at DRG | $3,081 | |
| Total Medicare payment per Day with ICD D287 - Benign neoplasm of other specified female genital organs | $2,735 | |
| Total Medicare payment per Hospitalization at DRG | $5,746 | |
| Total Medicare payment per Hospitalization with ICD D287 - Benign neoplasm of other specified female genital organs | $6,581 | |
| Total Medicare Charges at DRG | $1,015,345,035 | |
| Total Medicare Charges with ICD D287 - Benign neoplasm of other specified female genital organs | $2,584,567 | |
| Avg Charges at DRG | $41,587 | |
| Avg Charges with ICD D287 - Benign neoplasm of other specified female genital organs | $40,384 | |
| Mortality Rate at DRG | NA | |
| Mortality Rate with ICD D287 - Benign neoplasm of other specified female genital organs | NA | |
| SNF Discharge Rate at DRG | 1.08 | |
| SNF Discharge Rate with ICD D287 - Benign neoplasm of other specified female genital organs | NA | |
| Home Discharge Rate at DRG | 95.44 | |
| Home Discharge Rate with ICD D287 - Benign neoplasm of other specified female genital organs | 96.88 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 743: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 742: UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 24,415 | |
| Total Hospitalizations with ICD D287 - Benign neoplasm of other specified female genital organs | 77 | |
| DRG Share of Total Hospitalizations | 0.07 | |
| % of Total ICD D287 - Benign neoplasm of other specified female genital organs in DRG | 28.52 | |
| Avg LOS at DRG | 1.87 | |
| Avg LOS with ICD D287 - Benign neoplasm of other specified female genital organs | 2.29 | |
| Readmission Rate at DRG | 4.31 | |
| Readmission Rate with ICD D287 - Benign neoplasm of other specified female genital organs | NA | |
| Unplanned Readmission Rate at DRG | 3.22 | |
| Unplanned Readmission Rate with ICD D287 - Benign neoplasm of other specified female genital organs | NA | |
| Total Medicare payments at DRG | $140,286,858 | |
| Total Medicare payments with ICD D287 - Benign neoplasm of other specified female genital organs | $485,552 | |
| Total Medicare payment per Day at DRG | $3,081 | |
| Total Medicare payment per Day with ICD D287 - Benign neoplasm of other specified female genital organs | $2,759 | |
| Total Medicare payment per Hospitalization at DRG | $5,746 | |
| Total Medicare payment per Hospitalization with ICD D287 - Benign neoplasm of other specified female genital organs | $6,306 | |
| Total Medicare Charges at DRG | $1,015,345,035 | |
| Total Medicare Charges with ICD D287 - Benign neoplasm of other specified female genital organs | $3,011,283 | |
| Avg Charges at DRG | $41,587 | |
| Avg Charges with ICD D287 - Benign neoplasm of other specified female genital organs | $39,108 | |
| Mortality Rate at DRG | NA | |
| Mortality Rate with ICD D287 - Benign neoplasm of other specified female genital organs | NA | |
| SNF Discharge Rate at DRG | 1.08 | |
| SNF Discharge Rate with ICD D287 - Benign neoplasm of other specified female genital organs | NA | |
| Home Discharge Rate at DRG | 95.44 | |
| Home Discharge Rate with ICD D287 - Benign neoplasm of other specified female genital organs | 94.81 |